Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CGNX vs VNT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VNT Captures Overall Composite Edge (32.1 SELL vs 59.5 HOLD), While CGNX Leads 5–1 on Growth & Valuation Pillars

VNT Overall Winner 6-Pillar Tally: CGNX 5 – 1 VNT Matrix Metrics: CGNX 5 – 5 VNT

As of Nov 16, 2026, Vontier Corporation (VNT) captures the overall head-to-head institutional edge over Cognex Corp (CGNX) on higher Unified Composite conviction (32.1/100 SELL vs. 59.5/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples), while CGNX wins 5–1 across the 6-pillar growth and valuation breakdown. CGNX trades at $48.06 (24.7x Forward P/E, 25.0% operating margin) versus VNT at $43.79 (11.2x Forward P/E, 19.8% operating margin).

  • Composite vs. Pillar Nuance: While CGNX currently prints a higher short-term Unified Composite Score (59.5/100 HOLD vs. VNT 32.1/100 SELL), VNT captures the overall institutional head-to-head verdict (5–5 matrix metrics and 1–5 across the 6 pillars) due to superior fundamental profitability (19.8% vs. 25.0% operating margin) and revenue trajectory (-2.1% vs. +13.2% YoY).
  • Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile VNT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 81.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGNX vs VNT
CGNX NASDAQ
Cognex Corp
Industrial Instruments For Measurement, Display, And Control
$48.06
-3.9% 1D
Market Cap $8.5B
TTM Revenue $1.13B
Forward P/E 24.7x
Beta / 30D Vol 2.19β · 65% Vol
Unified Composite Score
59.5 / 100 HOLD
Tech 45.0 Fund 54.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.1%), weak momentum, RSI 36
RSI-14: 35.9 · SMA20: $53.86 · SMA50: $57.80
VNT NYSE Head-to-Head Winner
Vontier Corporation
Totalizing Fluid Meters & Counting Devices
$43.79
+0.34% 1D
Market Cap $5.7B
TTM Revenue $3.05B
Forward P/E 11.2x
Beta / 30D Vol 0.63β · 34% Vol
Unified Composite Score
32.1 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.7% over 20 days), RSI 81
RSI-14: 81.1 · SMA20: $38.37 · SMA50: $34.52

6-Pillar Scorecard Institutional Category Breakdown (CGNX 5 – 1 VNT)

Columns: Metric · CGNX · VNT
1. Valuation Multiples VNT
Forward P/E 24.7x 11.2x
Trailing P/E 35.5x 17.7x
PEG Ratio 2.71x 1.03x
EV / Revenue 7.0x 1.9x
2. Growth & Scale CGNX
Revenue Growth (YoY) +13.2% -2.1%
Earnings Growth (YoY) +400.0% +4.3%
TTM Revenue (USD) $1.13B $3.05B
Market Cap $8.5B $5.7B
3. Profitability & Quality CGNX
Gross Margin 69.7% 47.3%
Operating Margin 25.0% 19.8%
Net Profit Margin 21.5% 11.3%
Return on Equity (ROE) 15.1% 28.0%
4. Balance Sheet & Cash Flow CGNX
Cash Generation (TTM) $286M $713M EBITDA
Cash Flow Margin 25.4% 23.4% EBITDA Mgn
Net Cash / Leverage $624M Net Cash $9.03 Book/Sh · 28.0% ROE
Dividend Yield 0.66% 0.23%
5. Options & Positioning CGNX
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 53.5% (16th %ile) 23.0% (<1st %ile)
Put/Call OI Skew 1.96x (Put-Skewed) N/A
OBV Trend / Tech Phase ACCUMULATION · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat CGNX
OpEx & R&D Intensity 44.7% of Rev ($503M) 27.5% of Rev ($839M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Scientific & Technical Instruments Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGNX (5) vs VNT (5)
Institutional Metric CGNX VNT Criterion Row Edge
Market Capitalization
Scale
$8.5B $5.7B Larger Scale CGNX
Trailing P/E Ratio
Valuation
35.5x 17.7x Lower Multiple VNT
Forward P/E Ratio
Valuation
24.7x 11.2x Lower Multiple VNT
Revenue Growth (YoY)
Growth
+13.2% -2.1% Higher Growth CGNX
Operating Margin (TTM)
Profitability
25.0% 19.8% Higher Margin CGNX
Net Profit Margin
Profitability
21.5% 11.3% Higher Margin CGNX
Return on Equity (ROE)
Capital Efficiency
15.1% 28.0% Higher ROE VNT
52-Week Range Position
Momentum
35% ($35–$73) 79% ($27–$48) Stronger Trend VNT
Beta / 30D Volatility
Risk Regime
2.19β · 65% Vol 0.63β · 34% Vol Lower Realized Risk VNT
Unified Institutional Score
Composite Signal
59.5 / 100 (HOLD) 32.1 / 100 (SELL) Higher Composite CGNX
Trailing 12M Revenue (USD)
Operating Scale
$1.13B $3.05B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
69.7% 47.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.71x PEG · 7.0x EV/Rev 1.03x PEG · 1.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$286M ($624M Net Cash) $713M EBITDA ($9.03 Book/Sh · 28.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VNT +42.32 pp
CGNX: -10.98% · VNT: +31.34%
3M Horizon VNT +60.88 pp
CGNX: -24.21% · VNT: +36.67%
6M Horizon VNT +78.82 pp
CGNX: -22.37% · VNT: +56.45%
1Y Horizon CGNX +8.99 pp
CGNX: +29.72% · VNT: +20.73%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGNX vs VNT. Trailing 12-month operating profitability (CGNX 25.0% vs VNT 19.8%) and valuation multiples (CGNX 24.7x vs VNT 11.2x Forward P/E) are benchmarked directly in Pillar 4 below.

CGNX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.13B
Gross Margin69.7%
Op. Margin25.0%
ROE / Fwd P/E15.1% · 24.7x
VNT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.05B
Gross Margin47.3%
Op. Margin19.8%
ROE / Fwd P/E28.0% · 11.2x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGNX BREAKDOWN
120d in phase · OBV ACCUMULATION
Current IV 53.5%
IV Percentile 16th %ile
Put/Call OI Skew 1.96x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact CGNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VNT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 23.0%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGNX Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $8.5B market capitalization and 25.0% operating margin.
OpEx & R&D Reinvestment 44.7% of Rev ($503M)
90D Engineering Disclosures 0 Published
VNT Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $5.7B market capitalization and 19.8% operating margin.
OpEx & R&D Reinvestment 27.5% of Rev ($839M)
90D Engineering Disclosures 0 Published

Investor FAQ CGNX vs VNT Key Questions & Quantitative Answers

As of Nov 16, 2026, Vontier Corporation (VNT) captures the overall head-to-head institutional edge over Cognex Corp (CGNX) on higher Unified Composite conviction (32.1/100 SELL vs. 59.5/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples), while CGNX wins 5–1 across the 6-pillar growth and valuation breakdown. CGNX trades at $48.06 (24.7x Forward P/E, 25.0% operating margin) versus VNT at $43.79 (11.2x Forward P/E, 19.8% operating margin). Composite vs. Pillar Nuance: While CGNX currently prints a higher short-term Unified Composite Score (59.5/100 HOLD vs. VNT 32.1/100 SELL), VNT captures the overall institutional head-to-head verdict (5–5 matrix metrics and 1–5 across the 6 pillars) due to superior fundamental profitability (19.8% vs. 25.0% operating margin) and revenue trajectory (-2.1% vs. +13.2% YoY). Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile VNT trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 81.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CGNX leads the Growth & Scale pillar: CGNX posts +13.2% YoY revenue growth and +400.0% YoY earnings growth on $1.13B TTM revenue (69.7% gross margin, 25.0% operating margin), compared with VNT at -2.1% YoY revenue growth and +4.3% YoY earnings growth on $3.05B TTM revenue (47.3% gross margin, 19.8% operating margin). On trailing 12-month operating scale, CGNX generates $1.13B in USD-normalized revenue versus $3.05B for VNT. In operating R&D and SG&A reinvestment, CGNX deploys 44.7% of Rev ($503M) (0 90-day corporate R&D disclosures) versus 27.5% of Rev ($839M) (0 disclosures) for VNT.

VNT screens cheaper on headline valuation multiples. CGNX trades at 24.7x Forward P/E, 35.5x Trailing P/E, 2.71x PEG, and 7.0x EV/Revenue (25.4% FCF margin), whereas VNT trades at 11.2x Forward P/E, 17.7x Trailing P/E, 1.03x PEG, and 1.9x EV/Revenue (23.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNX (15.1% ROE) versus VNT (28.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CGNX carries 53.5% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.96x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.19β · 65% Vol realized risk). By comparison, VNT carries 23.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.63β · 34% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.